KYOTO UNIVERSITY HOSPITAL
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private, Subsidiary
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
123
Active:0
Completed:75
Trial Phases
5 Phases
Phase 1:6
Phase 2:14
Phase 3:3
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (117 trials with phase data)• Click on a phase to view related trials
Not Applicable
89 (76.1%)Phase 2
14 (12.0%)Phase 1
6 (5.1%)Phase 4
5 (4.3%)Phase 3
3 (2.6%)Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Phase 2
Recruiting
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2023-10-27
- Lead Sponsor
- Kyoto University Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05879653
- Locations
- 🇯🇵
Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
🇯🇵University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan
🇯🇵Kyoto University Hospital, Kyoto, Japan
News
No news found